Global Lymphoma Therapy Market Growth (Status and Outlook) 2022-2028
- LP 4891024
- 88 Pages
- March 2022
- Pharmaceuticals
The United States Lymphoma Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lymphoma Therapy market, reaching US$ million by the year 2028. As for the Europe Lymphoma Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Lymphoma Therapy players cover Roche, CHIPSCREEN, Johnson & Johnson, and Abbvie, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Lymphoma Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oral
Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
CHIPSCREEN
Johnson & Johnson
Abbvie
Celgene
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lymphoma Therapy Market Size 2017-2028
2.1.2 Lymphoma Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Lymphoma Therapy Segment by Type
2.2.1 Oral
2.2.2 Injection
2.3 Lymphoma Therapy Market Size by Type
2.3.1 Lymphoma Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Lymphoma Therapy Market Size Market Share by Type (2017-2022)
2.4 Lymphoma Therapy Segment by Application
2.4.1 Hodgkin Lymphoma
2.4.2 Non-Hodgkin Lymphoma
2.5 Lymphoma Therapy Market Size by Application
2.5.1 Lymphoma Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Lymphoma Therapy Market Size Market Share by Application (2017-2022)
3 Lymphoma Therapy Market Size by Player
3.1 Lymphoma Therapy Market Size Market Share by Players
3.1.1 Global Lymphoma Therapy Revenue by Players (2020-2022)
3.1.2 Global Lymphoma Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Lymphoma Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lymphoma Therapy by Regions
4.1 Lymphoma Therapy Market Size by Regions (2017-2022)
4.2 Americas Lymphoma Therapy Market Size Growth (2017-2022)
4.3 APAC Lymphoma Therapy Market Size Growth (2017-2022)
4.4 Europe Lymphoma Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Lymphoma Therapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Lymphoma Therapy Market Size by Country (2017-2022)
5.2 Americas Lymphoma Therapy Market Size by Type (2017-2022)
5.3 Americas Lymphoma Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lymphoma Therapy Market Size by Region (2017-2022)
6.2 APAC Lymphoma Therapy Market Size by Type (2017-2022)
6.3 APAC Lymphoma Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lymphoma Therapy by Country (2017-2022)
7.2 Europe Lymphoma Therapy Market Size by Type (2017-2022)
7.3 Europe Lymphoma Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lymphoma Therapy by Region (2017-2022)
8.2 Middle East & Africa Lymphoma Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Lymphoma Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lymphoma Therapy Market Forecast
10.1 Global Lymphoma Therapy Forecast by Regions (2023-2028)
10.1.1 Global Lymphoma Therapy Forecast by Regions (2023-2028)
10.1.2 Americas Lymphoma Therapy Forecast
10.1.3 APAC Lymphoma Therapy Forecast
10.1.4 Europe Lymphoma Therapy Forecast
10.1.5 Middle East & Africa Lymphoma Therapy Forecast
10.2 Americas Lymphoma Therapy Forecast by Country (2023-2028)
10.2.1 United States Lymphoma Therapy Market Forecast
10.2.2 Canada Lymphoma Therapy Market Forecast
10.2.3 Mexico Lymphoma Therapy Market Forecast
10.2.4 Brazil Lymphoma Therapy Market Forecast
10.3 APAC Lymphoma Therapy Forecast by Region (2023-2028)
10.3.1 China Lymphoma Therapy Market Forecast
10.3.2 Japan Lymphoma Therapy Market Forecast
10.3.3 Korea Lymphoma Therapy Market Forecast
10.3.4 Southeast Asia Lymphoma Therapy Market Forecast
10.3.5 India Lymphoma Therapy Market Forecast
10.3.6 Australia Lymphoma Therapy Market Forecast
10.4 Europe Lymphoma Therapy Forecast by Country (2023-2028)
10.4.1 Germany Lymphoma Therapy Market Forecast
10.4.2 France Lymphoma Therapy Market Forecast
10.4.3 UK Lymphoma Therapy Market Forecast
10.4.4 Italy Lymphoma Therapy Market Forecast
10.4.5 Russia Lymphoma Therapy Market Forecast
10.5 Middle East & Africa Lymphoma Therapy Forecast by Region (2023-2028)
10.5.1 Egypt Lymphoma Therapy Market Forecast
10.5.2 South Africa Lymphoma Therapy Market Forecast
10.5.3 Israel Lymphoma Therapy Market Forecast
10.5.4 Turkey Lymphoma Therapy Market Forecast
10.5.5 GCC Countries Lymphoma Therapy Market Forecast
10.6 Global Lymphoma Therapy Forecast by Type (2023-2028)
10.7 Global Lymphoma Therapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Lymphoma Therapy Product Offered
11.1.3 Roche Lymphoma Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 CHIPSCREEN
11.2.1 CHIPSCREEN Company Information
11.2.2 CHIPSCREEN Lymphoma Therapy Product Offered
11.2.3 CHIPSCREEN Lymphoma Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 CHIPSCREEN Main Business Overview
11.2.5 CHIPSCREEN Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Lymphoma Therapy Product Offered
11.3.3 Johnson & Johnson Lymphoma Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Abbvie
11.4.1 Abbvie Company Information
11.4.2 Abbvie Lymphoma Therapy Product Offered
11.4.3 Abbvie Lymphoma Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Abbvie Main Business Overview
11.4.5 Abbvie Latest Developments
11.5 Celgene
11.5.1 Celgene Company Information
11.5.2 Celgene Lymphoma Therapy Product Offered
11.5.3 Celgene Lymphoma Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Celgene Main Business Overview
11.5.5 Celgene Latest Developments
12 Research Findings and Conclusion
Table 1. Lymphoma Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Lymphoma Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Lymphoma Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Lymphoma Therapy Market Size Market Share by Type (2017-2022)
Table 7. Lymphoma Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Lymphoma Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Lymphoma Therapy Market Size Market Share by Application (2017-2022)
Table 10. Global Lymphoma Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Lymphoma Therapy Revenue Market Share by Player (2020-2022)
Table 12. Lymphoma Therapy Key Players Head office and Products Offered
Table 13. Lymphoma Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Lymphoma Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Lymphoma Therapy Market Size Market Share by Regions (2017-2022)
Table 18. Americas Lymphoma Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Lymphoma Therapy Market Size Market Share by Country (2017-2022)
Table 20. Americas Lymphoma Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Lymphoma Therapy Market Size Market Share by Type (2017-2022)
Table 22. Americas Lymphoma Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Lymphoma Therapy Market Size Market Share by Application (2017-2022)
Table 24. APAC Lymphoma Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Lymphoma Therapy Market Size Market Share by Region (2017-2022)
Table 26. APAC Lymphoma Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Lymphoma Therapy Market Size Market Share by Type (2017-2022)
Table 28. APAC Lymphoma Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Lymphoma Therapy Market Size Market Share by Application (2017-2022)
Table 30. Europe Lymphoma Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Lymphoma Therapy Market Size Market Share by Country (2017-2022)
Table 32. Europe Lymphoma Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Lymphoma Therapy Market Size Market Share by Type (2017-2022)
Table 34. Europe Lymphoma Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Lymphoma Therapy Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Lymphoma Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Lymphoma Therapy Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Lymphoma Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Lymphoma Therapy Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Lymphoma Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Lymphoma Therapy Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Lymphoma Therapy
Table 43. Key Market Challenges & Risks of Lymphoma Therapy
Table 44. Key Industry Trends of Lymphoma Therapy
Table 45. Global Lymphoma Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Lymphoma Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Lymphoma Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Lymphoma Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Lymphoma Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Lymphoma Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 51. Roche Details, Company Type, Lymphoma Therapy Area Served and Its Competitors
Table 52. Roche Lymphoma Therapy Product Offered
Table 53. Roche Lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. CHIPSCREEN Details, Company Type, Lymphoma Therapy Area Served and Its Competitors
Table 57. CHIPSCREEN Lymphoma Therapy Product Offered
Table 58. CHIPSCREEN Main Business
Table 59. CHIPSCREEN Lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. CHIPSCREEN Latest Developments
Table 61. Johnson & Johnson Details, Company Type, Lymphoma Therapy Area Served and Its Competitors
Table 62. Johnson & Johnson Lymphoma Therapy Product Offered
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Johnson & Johnson Latest Developments
Table 66. Abbvie Details, Company Type, Lymphoma Therapy Area Served and Its Competitors
Table 67. Abbvie Lymphoma Therapy Product Offered
Table 68. Abbvie Main Business
Table 69. Abbvie Lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Abbvie Latest Developments
Table 71. Celgene Details, Company Type, Lymphoma Therapy Area Served and Its Competitors
Table 72. Celgene Lymphoma Therapy Product Offered
Table 73. Celgene Main Business
Table 74. Celgene Lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Celgene Latest Developments
List of Figures
Figure 1. Lymphoma Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lymphoma Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Lymphoma Therapy Market Size Market Share by Type in 2021
Figure 7. Lymphoma Therapy in Hodgkin Lymphoma
Figure 8. Global Lymphoma Therapy Market: Hodgkin Lymphoma (2017-2022) & ($ Millions)
Figure 9. Lymphoma Therapy in Non-Hodgkin Lymphoma
Figure 10. Global Lymphoma Therapy Market: Non-Hodgkin Lymphoma (2017-2022) & ($ Millions)
Figure 11. Global Lymphoma Therapy Market Size Market Share by Application in 2021
Figure 12. Global Lymphoma Therapy Revenue Market Share by Player in 2021
Figure 13. Global Lymphoma Therapy Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Lymphoma Therapy Market Size 2017-2022 ($ Millions)
Figure 15. APAC Lymphoma Therapy Market Size 2017-2022 ($ Millions)
Figure 16. Europe Lymphoma Therapy Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Lymphoma Therapy Market Size 2017-2022 ($ Millions)
Figure 18. Americas Lymphoma Therapy Value Market Share by Country in 2021
Figure 19. Americas Lymphoma Therapy Consumption Market Share by Type in 2021
Figure 20. Americas Lymphoma Therapy Market Size Market Share by Application in 2021
Figure 21. United States Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Lymphoma Therapy Market Size Market Share by Region in 2021
Figure 26. APAC Lymphoma Therapy Market Size Market Share by Application in 2021
Figure 27. China Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Lymphoma Therapy Market Size Market Share by Country in 2021
Figure 34. Europe Lymphoma Therapy Market Size Market Share by Type in 2021
Figure 35. Europe Lymphoma Therapy Market Size Market Share by Application in 2021
Figure 36. Germany Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Lymphoma Therapy Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Lymphoma Therapy Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Lymphoma Therapy Market Size Market Share by Application in 2021
Figure 44. Egypt Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Lymphoma Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 50. APAC Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 51. Europe Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 53. United States Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 54. Canada Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 57. China Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 58. Japan Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 59. Korea Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 61. India Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 62. Australia Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 63. Germany Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 64. France Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 65. UK Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 66. Italy Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 67. Russia Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 68. Spain Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Israel Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Lymphoma Therapy Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
